| P50 | author | Evelyne Jacqz-Aigrain | Q37828693 |
| P2093 | author name string | C Mura | |
| | R Krishnamoorthy | |
| | M Vincent-Viry | |
| | M M Galteau | |
| | S Panserat | |
| | N Gérard | |
| P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
| | High-resolution crystal structure of cytochrome P450cam | Q27728724 |
| | Crystal structure of substrate-free Pseudomonas putida cytochrome P-450 | Q27728948 |
| | Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism | Q33245041 |
| | Characterization of the common genetic defect in humans deficient in debrisoquine metabolism | Q34049056 |
| | Defective N-oxidation of sparteine in man: A new pharmacogenetic defect | Q34053243 |
| | Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes | Q34083456 |
| | The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotype | Q34843826 |
| | Molecular genetic analysis of the cytochrome P450-debrisoquine hydroxylase locus and association with cancer susceptibility | Q34844253 |
| | The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene | Q35197475 |
| | Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22. | Q36455144 |
| | Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics | Q37913119 |
| | Site-directed mutageneses of rat liver cytochrome P-450d: axial ligand and heme incorporation | Q38347237 |
| | Phenotypic differences in dextromethorphan metabolism | Q42160979 |
| | Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population | Q44115646 |
| | Identification of the primary gene defect at the cytochrome P450 CYP2D locus | Q48250898 |
| | Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility. | Q53489724 |
| | Metabolic oxidation phenotypes as markers for susceptibility to lung cancer | Q59082319 |
| | DNA haplotype dependency of debrisoquine 4-hydroxylase (CYP2D6) expression among extensive metabolisers | Q61591076 |
| | A polymorphic CfoI site in exon 6 of the human cytochrome P450 CYP2D6 gene detected by the polymerase chain reaction | Q63241988 |
| | Mutant debrisoquine hydroxylation genes in Parkinson's disease | Q63241990 |
| | Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease | Q67516972 |
| | Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypes | Q67652737 |
| | Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences | Q67728153 |
| | Evidence in humans for variant allozymes of the nondeficient sparteine/debrisoquine monooxygenase (P45OIID 1) in vitro | Q69372084 |
| | Localization of the CYP2D gene locus to human chromosome 22q13.1 by polymerase chain reaction, in situ hybridization, and linkage analysis | Q70600229 |
| | Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: polymorphism in RFLP and DNA sequence of CYP2D6 | Q72216677 |
| | A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease | Q72660688 |
| | The 2.6-A crystal structure of Pseudomonas putida cytochrome P-450 | Q93648813 |
| P433 | issue | 4 | |
| P304 | page(s) | 401-406 | |
| P577 | publication date | 1994-10-01 | |
| P1433 | published in | Human Genetics | Q5937167 |
| P1476 | title | DNA haplotype-dependent differences in the amino acid sequence of debrisoquine 4-hydroxylase (CYP2D6): evidence for two major allozymes in extensive metabolisers | |
| P478 | volume | 94 | |